The identification of BCL-W as a previously unrecognized key contributor to B cell lymphoma has substantially aided in increasing our understanding of the BCL-2 family and the alterations in their expression that contribute to B cell lymphoma survival and therapy resistance. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.